IL-2-Inducible T Cell Kinase Deficiency Enables Development of Sustainable Chimeric Antigen Receptor T Cell Therapy
Year: 2024
Type: conference-abstract
Source: Blood
Authors: Zineng Huang, Hao Xu, Qingbai Liu, Jing Li, Keqing Song, Yating Deng, Yujia Tao, Huifang Zhang, Peilong Wang, Heng Li, Yue Sheng, Aijun Zhou, Lianbin Han, Yan Fu, Chenzhi Wang, Saurav Kumar Choudhary, Kaixiong Ye, Gianluca Veggiani, Avery August, Zhihong Li, Weishan Huang, Qiang Shan, Hongling Peng, Zheng Fu
Institutions: Second Xiangya Hospital of Central South University, Chinese Academy of Medical Sciences & Peking Union Medical College, Suzhou Institute of Systems Medicine, Kangda College of Nanjing Medical University, Nanjing Medical University, University of Georgia, Louisiana State University, Cornell University, New York State College of Veterinary Medicine
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4405038661